..... Meanwhile, Bumblebee Biotech offers this analysis of Alnylam Pharmaceuticals (ALNY - Cramer's Take - Stockpickr - Rating). Alnylam -- along with Sirna Therapeutics (RNAI - Cramer's Take - Stockpickr - Rating), CytRx (CYTR - Cramer's Take - Stockpickr - Rating) and numerous other private firms such as Calando -- is developing the most promising drug treatments based on RNAi since the discovery of recombinant DNA and the founding of Genentech (DNA - Cramer's Take - Stockpickr - Rating) in the '70s.
Alnylam is smart enough look [to] elsewhere for its drug delivery technology, and therefore ahead of the game. Inex Pharmaceuticals ... is the drug platform match to Alnylam. In our opinion, Alnylam is the only firm with a potentially workable drug delivery partner. Neither CytRx nor Sirna Therapeutics have known drug delivery partners, which is a critical issue.